Chemotherapy is well known to promote the emergence of dormant cancer cells, often referred to as drug-tolerant persisters [1, 15, 40] which are characterized by both down- [1, 13] and upregulated [41–43] mTOR signaling. This evidence concerns the gene MTOR and cancer.